Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Therapy Name||HA-1 TCR T cells|
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|HA-1 TCR T cells||CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR||HA-1 TCR T cells are CD8 and CD4 positive T-cells that have been engineered to express a T-cell receptor (TCR) that targets HA-1, potentially resulting in increased immune response against HA-1-expressing tumor cells (PMID: 29051183).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT03326921||Phase I||Fludarabine HA-1 TCR T cells||HA-1 T TCR T Cell Immunotherapy for the Treating of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant||Recruiting|